Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

509 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease.
Sachan V, Le Dévéhat M, Roubtsova A, Essalmani R, Laurendeau JF, Garçon D, Susan-Resiga D, Duval S, Mikaeeli S, Hamelin J, Evagelidis A, Chong M, Paré G, Chernetsova E, Gao ZH, Robillard I, Ruiz M, Trinh VQ, Estall JL, Faraj M, Austin RC, Sauvageau M, Prat A, Kiss RS, Seidah NG. Sachan V, et al. Among authors: pare g. Metabolism. 2024 Jan;150:155736. doi: 10.1016/j.metabol.2023.155736. Epub 2023 Nov 13. Metabolism. 2024. PMID: 37967646
Genetic Determinants of Vascular Dementia.
Pathan N, Kharod MK, Nawab S, Di Scipio M, Paré G, Chong M. Pathan N, et al. Among authors: pare g. Can J Cardiol. 2024 Aug;40(8):1412-1423. doi: 10.1016/j.cjca.2024.03.025. Epub 2024 Apr 3. Can J Cardiol. 2024. PMID: 38579965 Free article. Review.
Corrigendum to "PCSK7: A novel regulator of apolipoprotein B and a potential target against non-alcoholic fatty liver disease" [Metabolism Volume 150, January 2024, 155736, PMID: 7967646].
Sachan V, LeDévéhat M, Roubtsova A, Essalmani R, Laurendeau JF, Garçon D, Susan-Sesiga D, Duval S, Mikaeeli S, Hamelin J, Evagelidis A, Chong M, Paré G, Chernetsova E, Gao ZH, Robillard I, Ruiz M, Trinh VQ, Estall JL, Faraj M, Austin RC, Sauvageau M, Prat A, Kiss RS, Seidah NG. Sachan V, et al. Among authors: pare g. Metabolism. 2024 Dec;161:156032. doi: 10.1016/j.metabol.2024.156032. Epub 2024 Sep 19. Metabolism. 2024. PMID: 39298889 No abstract available.
A novel multi-ancestry proteome-wide Mendelian randomization study implicates extracellular proteins, tubular cells, and fibroblasts in estimated glomerular filtration rate regulation.
Lanktree MB, Perrot N, Smyth A, Chong M, Narula S, Shanmuganathan M, Kroezen Z, Britz-Mckibbin P, Berger M, Krepinsky JC, Pigeyre M, Yusuf S, Paré G. Lanktree MB, et al. Among authors: pare g. Kidney Int. 2023 Dec;104(6):1170-1184. doi: 10.1016/j.kint.2023.08.025. Epub 2023 Sep 27. Kidney Int. 2023. PMID: 37774922 Free article.
Surrogate Adiposity Markers and Mortality.
Khan I, Chong M, Le A, Mohammadi-Shemirani P, Morton R, Brinza C, Kiflen M, Narula S, Akhabir L, Mao S, Morrison K, Pigeyre M, Paré G. Khan I, et al. Among authors: pare g. JAMA Netw Open. 2023 Sep 5;6(9):e2334836. doi: 10.1001/jamanetworkopen.2023.34836. JAMA Netw Open. 2023. PMID: 37728925 Free PMC article.
Effects of routine early treatment with PCSK9 inhibitors in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a randomised, double-blind, sham-controlled trial.
Mehta SR, Pare G, Lonn EM, Jolly SS, Natarajan MK, Pinilla-Echeverri N, Schwalm JD, Sheth TN, Sibbald M, Tsang M, Valettas N, Velianou JL, Lee SF, Ferdous T, Nauman S, Nguyen H, McCready T, McQueen MJ. Mehta SR, et al. Among authors: pare g. EuroIntervention. 2022 Dec 2;18(11):e888-e896. doi: 10.4244/EIJ-D-22-00735. EuroIntervention. 2022. PMID: 36349701 Free PMC article. Clinical Trial.
509 results